{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:33:12Z","timestamp":1792549992381,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2019ZX09301-150"],"award-info":[{"award-number":["2019ZX09301-150"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["BK2019001"],"award-info":[{"award-number":["BK2019001"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microsatellite instability (MSI) has emerged as an important predictor of sensitivity for immunotherapy-based strategies. \u03b2-2-Microglobulin (B2M) contains microsatellites within the coding regions and is prone to somatic changes in MSI\/mismatch repair deficiency (MSI\/dMMR) tumors. To delineate prevalence and associations of B2M mutations in MSI-H\/dMMR cancers, we investigated the mutational profile of B2M and clinical and pathological features in gastric cancer (GC), colorectal cancer (CRC), and endometrial cancer (EC) with a high incidence of microsatellite instability-high (MSI-H)\/dMMR. Formalin-fixed paraffin-embedded (FFPE) tumor tissues along with matched normal tissues were collected from 108 MSI\/dMMR patients with GC, CRC, and EC. Genomic profiling of tissue and blood samples were assessed next-generation sequencing (NGS). Immunohistochemistry (IHC) was used to examine the presence or absence of B2M protein. Alternations in the exonic microsatellite regions of B2M were observed at various but high frequencies (57.5% in CRC, 23.9% in GC, and 13.6% in EC) and in different forms. NGS assay revealed that genes involved in chromatin regulation, the PI3K pathway, the WNT pathway, and mismatch repair were extensively altered in the MSI-H cohort. Signature 6 and 26, 2 of 4 mutational signatures associated with defective DNA mismatch repair, featured with high numbers of small insertion\/deletions (INDEL) dominated in all 3 types of cancer. Alternations in the exonic microsatellite regions of B2M were observed at various but high frequencies (57.5% in CRC, 23.9% in GC, and 13.6% in EC) and in different forms. Tumor mutational burden (TMB) was significantly higher in the patients carrying MSI-H\/dMMR tumors with B2M mutation than that in patients with wild-type B2M (P = .026).The frame shift alteration occurring at the exonic microsatellite sties caused loss of function of B2M gene. In addition, a case with CRC carrying indels in B2M gene resisted the ICI treatment was reported. In conclusion, patients carrying MSI-H\/dMMR tumors with B2M mutation showed significantly higher TMB. Prescription of ICIs should be thoroughly evaluated for these patients.<\/jats:p>","DOI":"10.1093\/oncolo\/oyac268","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:45:28Z","timestamp":1671788728000},"page":"e136-e144","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H\/dMMR Cancers"],"prefix":"10.1093","volume":"28","author":[{"given":"Fangcen","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Margaret Williamson Red House Hospital , Shanghai , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of R&D, OrigiMed , Shanghai , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Che","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaochun","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of R&D, OrigiMed , Shanghai , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandie","family":"Wu","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Qian","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of R&D, OrigiMed , Shanghai , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[{"name":"The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University , Nanjing , People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/nm.4191","article-title":"Classification and characterization of microsatellite instability across 18 cancer types","volume":"22","author":"Hause","year":"2016","journal-title":"Nat Med"},{"key":"2023041012083667400_","first-page":"e15","article-title":"Microsatellite instability: a predictive biomarker for cancer immunotherapy","volume":"26","author":"Chang","year":"2018","journal-title":"AIMM."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","article-title":"Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study","volume":"133","author":"Jenkins","year":"2007","journal-title":"Gastroenterology"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/2326-6066.CIR-19-0149","article-title":"Microsatellite-stable tumors with high mutational burden benefit from immunotherapy","volume":"7","author":"Goodman","year":"2019","journal-title":"Cancer Immunol. Res"},{"issue":"Pt 1","key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3380001","article-title":"Recognition of DNA alterations by the mismatch repair system","volume":"338","author":"Marra","year":"1999","journal-title":"Biochem J"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.1298","article-title":"Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens","volume":"93","author":"Linnebacher","year":"2001","journal-title":"Int J Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trecan.2016.02.004","article-title":"The immune biology of microsatellite-unstable cancer","volume":"2","author":"Kloor","year":"2016","journal-title":"Trends Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2174\/138955710793564098","article-title":"Microsatellite instability (MSI) as genomic markers in endometrial cancer: toward scientific evidences","volume":"10","author":"Tinelli","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.ejca.2010.05.009","article-title":"Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data","volume":"46","author":"Guastadisegni","year":"2010","journal-title":"Eur. J. Cancer."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms","volume":"121","author":"Sahin","year":"2019","journal-title":"Br J Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/br.2013.53","article-title":"\u03b2-2 Microglobulin is unsuitable as an internal reference gene for the analysis of gene expression in human colorectal cancer","volume":"1","author":"Nihon-Yanagi","year":"2013","journal-title":"Biomedical Reports"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/bjc.2012.53","article-title":"Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial","volume":"106","author":"Tikidzhieva","year":"2012","journal-title":"Br J Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-immunol-032712-095912","article-title":"The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules","volume":"31","author":"Adams","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","article-title":"Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo","volume":"38","author":"Halle","year":"2017","journal-title":"Trends Immunol"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00262-012-1321-6","article-title":"Implication of the \u03b22-microglobulin gene in the generation of tumor escape phenotypes","volume":"61","author":"Bernal","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ijc.22691","article-title":"Beta2-microglobulin mutations in microsatellite unstable colorectal tumors","volume":"121","author":"Kloor","year":"2007","journal-title":"Int J Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1155\/2004\/136734","article-title":"Development of a fluorescent multiplex assay for detection of MSI-High tumors","volume":"20","author":"Bacher","year":"2004","journal-title":"Dis Markers"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jmoldx.2010.12.004","article-title":"Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry","volume":"13","author":"Cicek","year":"2011","journal-title":"J Mol Diagn."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsd\u00f3ttir","year":"2013","journal-title":"Brief Bioinform"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-17-0787","article-title":"Genetic predictors of response to systemic therapy in esophagogastric cancer","volume":"8","author":"Janjigian","year":"2018","journal-title":"Cancer Discovery."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1158\/1078-0432.CCR-14-0567","article-title":"Genetic evolution of T-cell resistance in the course of melanoma progression","volume":"20","author":"Sucker","year":"2014","journal-title":"Clin Cancer Res."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41416-019-0514-6","article-title":"High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer","volume":"121","author":"Pfuderer","year":"2019","journal-title":"Br J Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor mutational burden as a predictive biomarker in solid tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","article-title":"Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy","volume":"517","author":"Wang","year":"2021","journal-title":"Cancer Lett"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMc1510353","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"373","author":"Asaoka","year":"2015","journal-title":"N Engl J Med"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bulcan.2018.08.007","article-title":"Why is immunotherapy effective (or not) in patients with MSI\/MMRD tumors?","volume":"106","author":"Nebot-Bral","year":"2019","journal-title":"Bull Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"2023041012083667400_","article-title":"Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high","volume":"3","author":"Middha","year":"2019","journal-title":"JCO Prec Oncol."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10689-017-0013-y","article-title":"Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas","volume":"17","author":"Clendenning","year":"2018","journal-title":"Fam Cancer"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/his.13895","article-title":"Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial","volume":"75","author":"Barrow","year":"2019","journal-title":"Histopathology"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3390\/jcm9061741","article-title":"Implications of hereditary origin on the immune phenotype of mismatch repair-deficient cancers: systematic literature review","volume":"9","author":"Bohaumilitzky","year":"2020","journal-title":"J Clin Med."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-17-1327","article-title":"Genetic mechanisms of immune evasion in colorectal cancer","volume":"8","author":"Grasso","year":"2018","journal-title":"Cancer Discov."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humpath.2017.09.019","article-title":"Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells","volume":"72","author":"Le Flahec","year":"2018","journal-title":"Hum Pathol"},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/2159-8290.CD-20-0987","article-title":"CD4 T cell-dependent rejection of beta-2 microglobulin null mismatch repair-deficient tumors","volume":"11","author":"Germano","year":"2021","journal-title":"Cancer Discov."},{"key":"2023041012083667400_","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/CJI.0000000000000417","article-title":"B2M and JAK1\/2-mutated MSI-H colorectal carcinomas can benefit from anti-PD-1 therapy","volume":"45","author":"Zhang","year":"2022","journal-title":"J Immunother."}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/3\/e136\/49806728\/oyac268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/3\/e136\/49806728\/oyac268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T08:20:27Z","timestamp":1701591627000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/28\/3\/e136\/7022155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,1]]},"published-print":{"date-parts":[[2023,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyac268","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,2,1]]}}}